U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C11H21N3O5
Molecular Weight 275.3015
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of LYSYLGLUTAMIC ACID

SMILES

NCCCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(O)=O

InChI

InChIKey=UGTZHPSKYRIGRJ-YUMQZZPRSA-N
InChI=1S/C11H21N3O5/c12-6-2-1-3-7(13)10(17)14-8(11(18)19)4-5-9(15)16/h7-8H,1-6,12-13H2,(H,14,17)(H,15,16)(H,18,19)/t7-,8-/m0/s1

HIDE SMILES / InChI

Molecular Formula C11H21N3O5
Molecular Weight 275.3015
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

PubMed

PubMed

TitleDatePubMed
[The use of peptide bioregulators for cancer prevention: results of 35 years of research experience and perspectives].
2009
Comparative analysis of the expression of c-Fos and interleukin-2 proteins in hypothalamus cells during various treatments.
2008-03
[Parallel analysis of c-Fos protein and interleukin-2 expression in hypothalamic cells under different influence].
2007-02
[Effect of vilon on the immunity status and coagulation hemostasis in patients of different age with diabetes mellitus].
2007
Interleukin-2 concentration in hypothalamic structures of rats receiving peptides during mild stress.
2006-04
Anti-aging peptide bioregulators induce reactivation of chromatin.
2006-04
[Effect of thymomimetic vilon on blood coagulation system and fibrinolisis in diabetes mellitus type 1 patients of different age].
2006
[Effect of vilon on neuroendocrine status and sexual function of old male rats].
2006
Effect of peptide Vilon on the content of transforming growth factor-beta and permeability of microvessels during experimental chronic renal failure.
2005-01
[The effect of vilon (Lys-Glu) on 1.2-dimethylhydrazine-induced neoplasia].
2005
[Application of peptide bioregulator in complex treatment of elderly cancer patients].
2005
[Vilon effect on consequences of repeated radioactive and mercuric impact in small doses].
2005
Expression of argyrophilic proteins in the nucleolar organizer regions of human thymocytes and thymic epitheliocytes under conditions of coculturing with vilon and epithalon peptides.
2004-06
[The study of peptide effect in the mechanisms of angiogenesis and forming of microenvironment of the tumors in old rats].
2004
Bioregulator Vilon-induced reactivation of chromatin in cultured lymphocytes from old people.
2004
Modulating and protective effects of thymic peptides in lymphoid tissue culture.
2003-08-16
[The study of the role of the water medium in the mechanism of action of peptides in low and ultra low doses].
2003-07-29
Elucidation of the effect of brain cortex tetrapeptide Cortagen on gene expression in mouse heart by microarray.
2003-04-24
[Combined effect of vilon and cyclophosphane on tumor transplants and lymphoid tissue explants in mice and rats of various age].
2003
[Reciprocal relation of proliferative activity in central and peripheral zones of splenic organ culture exposed to vilon in rats of various ages].
2003
Effect of vilon and epithalon on activity of enzymes in epithelial and subepithelial layers in small intestine of old rats.
2002-12
[Effect of dipeptide vilon on emotional stress resistance in rats].
2002-11
Inhibitory effect of the peptide epitalon on the development of spontaneous mammary tumors in HER-2/neu transgenic mice.
2002-09-01
In vitro effect of short peptides on expression of interleukin-2 gene in splenocytes.
2002-06
Effects of short peptides on thymocyte blast transformation and signal transduction along the sphingomyelin pathway.
2002-05
Effect of Vilon and Epithalon on glucose and glycine absorption in various regions of small intestine in aged rats.
2002-05
Studies of the effects of Vilon and Epithalon on gene expression in mouse heart using DNA-microarray technology.
2002-03
Epithalon inhibits tumor growth and expression of HER-2/neu oncogene in breast tumors in transgenic mice characterized by accelerated aging.
2002-02
[Characteristics of effect of ultralow doses of vilon in organotypic culture of spleens from rats of various ages].
2002
[Effect of Epitalon and Vilon treatment on mammary carcinogenesis in transgenic erbB-2/NEU mice].
2002
[Functional morphology of organotypic culture of spleens from rats of various ages exposed to vilon].
2002
[The effect of vilon on the thymus and spleen in a radiation model of premature aging].
2002
Effects of peptides on generation of reactive oxygen species in subcellular fractions of Drosophila melanogaster.
2001-07
Effect of the dipeptide vilon on activity of digestive enzyme in rats of various ages.
2001-06
Inhibitory effect of peptide vilon on the development of induced rat urinary bladder tumors in rats.
2001-06
Immunohistochemical and morphometric analysis of effects of vilon and epithalon on functional morphology of radiosensitive organs.
2001-03
[Effect of vilon and epithalone on induction and growth of induced bladder neoplasms in rats].
2001
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 21:23:31 GMT 2025
Edited
by admin
on Mon Mar 31 21:23:31 GMT 2025
Record UNII
H34V7IM5ML
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
VILON
Preferred Name English
LYSYLGLUTAMIC ACID
Systematic Name English
L-GLUTAMIC ACID, L-LYSYL-
Common Name English
Code System Code Type Description
CHEBI
74557
Created by admin on Mon Mar 31 21:23:31 GMT 2025 , Edited by admin on Mon Mar 31 21:23:31 GMT 2025
PRIMARY
PUBCHEM
7010501
Created by admin on Mon Mar 31 21:23:31 GMT 2025 , Edited by admin on Mon Mar 31 21:23:31 GMT 2025
PRIMARY
FDA UNII
H34V7IM5ML
Created by admin on Mon Mar 31 21:23:31 GMT 2025 , Edited by admin on Mon Mar 31 21:23:31 GMT 2025
PRIMARY
CAS
45234-02-4
Created by admin on Mon Mar 31 21:23:31 GMT 2025 , Edited by admin on Mon Mar 31 21:23:31 GMT 2025
PRIMARY
EPA CompTox
DTXSID50196442
Created by admin on Mon Mar 31 21:23:31 GMT 2025 , Edited by admin on Mon Mar 31 21:23:31 GMT 2025
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
SOLVATE->ANHYDROUS